Clinical Trial Detail

NCT ID NCT01254864
Title Maximum Androgen Depletion
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

prostate cancer

Therapies

Abiraterone + Sunitinib

Abiraterone + Dasatinib

Age Groups: adult

No variant requirements are available.